IMV Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 92 252 sessions, April 28, 2022 to April 28, 2023
- Largest daily move
- +66.6% close of December 15, 2022
- 1-year change
- -93.2% closing prices, April 28, 2022 to April 28, 2023
- 1-month change
- +69.6% closing prices, March 28, 2023 to April 28, 2023
Company Description
IMV (Nasdaq: IMV) is classified in the biotechnology industry within the Healthcare sector.
IMV has declined 93.2% over the past year. The last closing price was $0.8225.
This page collects what Stock Titan holds for IMV, including price data and latest news.
Stock Performance
IMV (IMV) closed at $0.8225 on April 28, 2023. Over the past 12 months, the price has lost 93.2%.
IMV Metrics & Rankings
Price returns through April 28, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
IMV has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, conferences, clinical trial. View all IMV news →
SEC Filings
IMV Company Profile & Sector Positioning
IMV (IMV) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing IMV often look at related companies in the same sector, including IN8bio, Inc. (INAB), Diffusion Pharmaceuticals Inc. (DFFN), Bolt Biotherapeutics, Inc. (BOLT), Matinas BioPharma Holdings, Inc. (MTNB), and TransCode Therapeutics, Inc. (RNAZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IMV's relative position within its industry.